cells into the secondary lymphoid organs and within these organs. In the past, the working group managed to gain the fundamental insight that the chemokine receptor CXCR5 is responsible for the positioning

Research group Prof. Dr. Nico Lachmann Project Manager Dr. Dorothee Lachmann Email: Dorothee Lachmann Post Docs Dr. Mania Ackermann Phone: +49 511 532- 3325 Email: Mania Ackermann Dr. Anna Rafiei Hashtchin

nominated by the MHH senate for a term of three years. Contact Dr. rer. nat. Beate Schwinzer Scientific Manager OE 9100 Tel.: +49 (0) 511 532 6002 E-Mail: schwinzer.beate@mh-hannover.de GSP Commission Members

Gaby Froriep, coordinator of the PhD program "Regenerative Sciences" at MHH, and Lisa Braukmann (Management and Controlling Finance HTTG Research). The project represents a successful continuation of Prof

and preventive measures and research projects. The foundation is administered by the foundation management of Sparkasse Hannover GmbH. Further information about the association can be found here . Or contact

their researchers to publish with the publishers according to the Open Access model. The consortium, managed by MPDL Services gGmbH and supported by the German scientific organizations, processes around 30

network focuses on clinical and healthcare research, which directly benefits patients, affects crisis management and helps to establish a national research infrastructure. To realise this task, the NUM and the [...] project focuses on diseases such as bronchitis and pneumonia, improved diagnostics and therapy management of asthma, COPD, pulmonary emphysema, pulmonary fibrosis and the follow-up of late fibrotic damage [...] information can be found on the websites of GLOHRA and the Hannover Medical School . OnCoVID / Management in oncology during COVID-19 pandemic – ethical, legal and health-economic implications Project

is committed to improving patient care worldwide through the dissemination of a unified quality management system based on the current state of medical and pharmaceutical science and technology for the

journal The Lancet. "Our study shows a statistically clear improvement in overall survival and a manageable safety profile in patients with bile duct cancer," says Professor Dr Arndt Vogel from the Department

close coordination with the central animal laboratory of the MHH . A permanent staff (laboratory manager, technical assistants, laboratory technician) supervises the area on site and implements the tests